Court Approval of Samarco Australian Securities Class Action Settlement

The National Tribune
The Federal Court of Australia approved a AU$110 million settlement between BHP and shareholders in a class action related to Samarco.

Summary

The Federal Court of Australia has given its approval to the settlement of the Australian securities class action against BHP concerning the Samarco dam disaster. The settlement, initially disclosed on September 9, 2025, requires BHP to pay AU$110 million to the applicants, covering interest and costs, but does not involve any admission of liability. BHP anticipates recovering a significant portion of this settlement amount through its insurance coverage. This concludes the legal proceedings related to this specific shareholder claim.

(Source:The National Tribune)

WBRZ

$5M lawsuit claims Disney's California theme parks illegally collect facial recognition data

CP24 Toronto

Judge approves class action lawsuit launched by Quebec TV personality

The Bradenton Times

Maryland reaches $4.1M settlement with homebuilder in sediment pollution case

Tekedia

Tether Invests on LemFi to Accelerate Stablecoin Settlement Flow in Africa and Asia

Headtopics

President Trump, Family, and Businesses Shielded from Pending Tax Audits as Part of DOJ Settlement

Bitcoin News

Evernorth Highlights XRP’s ‘Actual Story’ Beyond JPMorgan Settlement Attention

Punch

SEC fixes June 1 for T+1 settlement cycle transition

Firstpost

Why is Trump’s new IRS settlement triggering allegations of ‘self-dealing’?

Syracuse Ny Local News

Government to permanently drop tax claims against Trump family as part of lawsuit settlement

USA TODAY

Disney sued over facial recognition at California theme parks

New York Post

Disneyland targeted in class-action lawsuit claiming new program is violating guests' privacy

Bangor Daily News

Journalists sue tech giants over 'stolen' voices for AI training

The Mercury News

Disneyland hit with $5 million lawsuit over use of facial recognition technology

Devdiscourse

UPDATE 4-Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

The Japan Times

Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury